The integrative amyloid-tau-mitochondrial hypothesis posits that risk factors and metabolic changes trigger a primary specific cause of AD development, which is mitochondrial dysfunction, neurotoxicity of Aβ oligomers or neurotoxicity of tau oligomers, and the mutual feedback and synergistic interactions of these primary causes lead to neurodegeneration. The gene discussed is MAPT; the disease is Alzheimer disease.